Pelvic Mesh Scandal: Women’s Compensation Claims Face Delays

The ongoing failure of the UK government to establish a compensation scheme for women harmed by pelvic mesh implants has drawn sharp criticism, with campaigners labeling the delay “morally unacceptable.” Thousands of women have experienced life-altering complications following transvaginal mesh surgery, including debilitating pain, mobility issues, and the inability to work.

February 8, 2026 marks two years since Dr. Henrietta Hughes, England’s patient safety commissioner, outlined plans for financial redress for those affected by pelvic mesh implants. The proposals, detailed in the 2024 Hughes report, also included provisions for children disabled as a result of their mothers’ use of the epilepsy drug sodium valproate during pregnancy.

Despite these recommendations, the government has yet to commit to providing compensation. Recent statements confirm there is still no firm timeline for delivering redress to victims of both pelvic mesh complications and valproate-related harm. Dr. Hughes has now stated her intention to directly address the issue with the Prime Minister.

The lack of action is taking a significant toll on the mental health of those affected, according to campaigners. Kath Sansom, founder of the advocacy group Sling the Mesh, described the situation as increasingly desperate. “As every week, month, year passes, women are getting more frustrated, upset. You can’t put their pain on hold. A lot of them have had to give up work or reduce their hours. They’re struggling to make ends meet. We have some members, they’ve had to sell their homes and move in with elderly parents, marriages broken down…” she stated. She further expressed her anger that women have had their lives ruined without accountability, calling the inaction “morally unacceptable.”

Pelvic mesh was once widely considered a gold standard treatment for stress incontinence and pelvic organ prolapse, conditions that can arise after childbirth or menopause. Sansom emphasized that patients were not adequately informed about the potential risks. “None of us were warned about the risks. We were all told it was a gold standard surgery,” she said.

Surgical removal of mesh can be a complex and challenging procedure, often resulting in further complications. Surgeons have likened the process to removing chewing gum from hair, highlighting the potential for organ injury, heavy bleeding, serious infection, and blood clots.

The Hughes report stemmed directly from the First Do No Harm review, led by Julia Cumberlege. This review identified nine recommendations aimed at achieving justice for women harmed by pelvic mesh, sodium valproate, and the hormone pregnancy test Primodos.

Labour MP Sharon Hodgson, whose mother suffered debilitating pain and infections following pelvic mesh implantation, condemned the government’s inaction as “insulting.” “No government response to the Hughes report after two long years since its publication is insulting to the thousands of mesh- and valproate-harmed women and children. Here’s more than just a response to a report; this is about restorative justice,” she stated. Hodgson, who chairs the First Do No Harm all-party parliamentary group, also highlighted the pattern of “gaslighting” experienced by these women, where their concerns were dismissed and their pain attributed to psychological factors.

“All of these women and the families, they were all gaslit. They were all told it was all in their heads: ‘There’s nothing wrong with you.’ And the women who would have children damaged by valproate, again, they [doctors] went: ‘Oh, this drug’s safe.’ So they’ve had years of being gaslit,” Hodgson explained. She believes that compensation would serve as a crucial acknowledgement of the harm caused and validate the experiences of those affected.

Dr. Hughes echoed this sentiment, stating, “These are not abstract policy questions; they are about real people whose lives have been fundamentally changed by systemic failures in healthcare. Every month of delay compounds the injustice these patients have already endured.” She affirmed her commitment to directly engaging with the Prime Minister to secure a commitment to action.

A spokesperson for the Department of Health and Social Care acknowledged the significant impact of sodium valproate and pelvic mesh on patients and their families. They stated that the issue is complex and that their priority is to ensure any response is “fair, balanced and sensitive.” The department confirmed they are carefully considering the recommendations within the Hughes report, in collaboration with other relevant departments, and aim to provide an update in the near future.

The situation underscores the critical importance of thorough risk assessment, informed consent, and ongoing monitoring in medical procedures. It also highlights the need for robust systems to address systemic failures in healthcare and provide timely and appropriate redress for those harmed.